CCS
ACRS icon

Crosspoint Capital Strategies’s Aclaris Therapeutics ACRS Stock Holding History

Crosspoint Capital Strategies’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-295
Closed -$9K – 140
2017
Q1 		$9K Hold
295
– – 0.01% 64
2016
Q4 		$8K Buy
+295
New +$8K 0.01% 67